Anne Yeakey

540 total citations
19 papers, 317 citations indexed

About

Anne Yeakey is a scholar working on Infectious Diseases, Epidemiology and Physiology. According to data from OpenAlex, Anne Yeakey has authored 19 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Epidemiology and 6 papers in Physiology. Recurrent topics in Anne Yeakey's work include Asthma and respiratory diseases (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Influenza Virus Research Studies (4 papers). Anne Yeakey is often cited by papers focused on Asthma and respiratory diseases (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Influenza Virus Research Studies (4 papers). Anne Yeakey collaborates with scholars based in United States, United Kingdom and Spain. Anne Yeakey's co-authors include David A. Stempel, Ibrahim Raphiou, Kenneth M. Kral, Steven Pascoe, Charlene M. Prazma, Amanda Emmett, Søren Pedersen, Barbara A. Prillaman, Herman Mitchell and Suyong Yun Kirby and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Anne Yeakey

19 papers receiving 308 citations

Peers

Countries citing papers authored by Anne Yeakey

Since Specialization

Citations

This map shows the geographic impact of Anne Yeakey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Yeakey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Yeakey more than expected).

Fields of papers citing papers by Anne Yeakey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Yeakey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Yeakey. The network helps show where Anne Yeakey may publish in the future.

Co-authorship network of co-authors of Anne Yeakey

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Yeakey. A scholar is included among the top collaborators of Anne Yeakey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Yeakey. Anne Yeakey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children 2024 ·Expert Review of Vaccines ·Frances Priddy, Spyros Chalkias, Brandon Essink, (unknown), Adam Brosz, Ivan T. Lee, Jing Feng, LaRee Tracy, Weiping Deng, (unknown), Haiyu Zhou, Avika Dixit, (unknown), Bethany Girard, (unknown), Anne Yeakey, Jacqueline M. Miller, Rituparna Das, Barbara J. Kuter	6
2	Safety and immunogenicity of a single-dose omicron-containing COVID-19 vaccination in adolescents: an open-label, single-arm, phase 2/3 trial 2024 ·The Lancet Infectious Diseases ·Amparo L. Figueroa, (unknown), (unknown), (unknown), Anne Yeakey, Weiping Deng, W. Xu, (unknown), (unknown), (unknown), Bethany Girard, Jacqueline M. Miller, Rituparna Das, Frances Priddy	1
3	Safety and durability of mRNA-1273–induced SARS-CoV-2 immune responses in adolescents: results from the phase 2/3 TeenCOVE trial 2024 ·EClinicalMedicine ·Amparo L. Figueroa, (unknown), Gary Berman, Haiyu Zhou, Weiping Deng, W. Xu, Stephanie Lussier, Bethany Girard, (unknown), Karen Slobod, Anne Yeakey, Frances Priddy, Jacqueline M. Miller, Rituparna Das	5
4	367. Safety and Immunogenicity of a 50-μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in Adolescents 2023 ·Open Forum Infectious Diseases ·Amparo L. Figueroa, (unknown), Gary Berman, Haiyu Zhou, Weiping Deng, (unknown), Bethany Girard, Anne Yeakey, Karen Slobod, Frances Priddy, Jacqueline M. Miller, Rituparna Das	1
5	DREAMM-9: Phase I Study of Belantamab Mafodotin Plus Standard of Care in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma 2021 ·Blood ·Saad Z. Usmani, (unknown), Hang Quach, Youngil Koh, Andreas Guenther, Chang‐Ki Min, (unknown), Morrys C. Kaisermann, (unknown), (unknown), Anne Yeakey, Geraldine Ferron‐Brady, David J. Figueroa, Brandon E. Kremer, Ira Gupta, Wojciech Janowski	15
6	Effect of raxibacumab on immunogenicity of Anthrax Vaccine Adsorbed: a phase 4, open-label, parallel-group, randomised non-inferiority study 2020 ·The Lancet Infectious Diseases ·(unknown), Jie Wang‐Jairaj, Oscar Della Pasqua, Vijayalakshmi Chandrasekaran, Julia Billiard, Anne Yeakey, William B. Smith, Helen Steel, Lionel Tan	14
7	DREAMM-5 platform trial: Belantamab mafodotin in combination with novel agents in patients with relapsed/refractory multiple myeloma (RRMM). 2020 ·Journal of Clinical Oncology ·Paul G. Richardson, Swethajit Biswas, Beata Holkova, Nicola Jackson, (unknown), Sofia Paul, Geraldine Ferron‐Brady, Anne Yeakey, (unknown), Rocío Montes de, Christoph M. Ahlers, Marc Ballas, Elaine Paul, Ira Gupta, Joanna Opalińska, Katarina Luptakova	4
8	DREAMM-6: Safety and tolerability of belantamab mafodotin in combination with bortezomib/dexamethasone in relapsed/refractory multiple myeloma (RRMM). 2020 ·Journal of Clinical Oncology ·Ajay K. Nooka, Keith Stockerl‐Goldstein, Hang Quach, Adam Forbes, María‐Victoria Mateos, Amit Khot, Alan Tan, Rafat Abonour, Bikramjit Chopra, Rachel Rogers, Geraldine Ferron‐Brady, (unknown), Steve Frey, Anne Yeakey, Mala K. Talekar, Katarina Luptakova, Ira Gupta, Rakesh Popat	32
9	Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis 2019 ·Advances in Therapy ·Gaël Dos Santos, (unknown), Silvia Damaso, Anne Yeakey	4
10	Passive enhanced safety surveillance of GSK’s quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain, an observational study: protocol for the 2018/2019 influenza season 2019 ·BMJ Open ·Gaël Dos Santos, Anne Yeakey, (unknown), Katie Smith, (unknown), (unknown), Silvia Damaso, Alexander C. Schmidt	4
11	Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season 2019 ·Drug Safety ·Gaël Dos Santos, Bach‐Yen Nguyen, Silvia Damaso, Lode Godderis, Xavier Martínez‐Gómez, (unknown), (unknown), Ignacio Salamanca de la Cueva, (unknown), Alexander C. Schmidt, Anne Yeakey	8
12	Dreamm-5: Platform Trial Evaluating Belantamab Mafodotin (a BCMA-directed Immuno-conjugate) in Combination with Novel Agents in Relapsed or Refractory Multiple Myeloma (RRMM) 2019 ·Blood ·Paul G. Richardson, Swethajit Biswas, Beata Holkova, Nicola Jackson, (unknown), Weichao Bao, Geraldine Ferron‐Brady, Anne Yeakey, (unknown), Rocío Montes de, (unknown), Sonia Franco, Marc Ballas, Elaine Paul, Katarina Luptakova, Ira Gupta, Joanna Opalinska	7
13	Enhanced passive surveillance of influenza vaccination in England, 2016−2017– an observational study using an adverse events reporting card 2019 ·Human Vaccines & Immunotherapeutics ·Simon de Lusignan, Filipa Ferreira, Silvia Damaso, Rachel Byford, Sameera Pathirannehelage, Anne Yeakey, Ivelina Yonova, Anne Schuind, Gaël Dos Santos	17
14	Austri, a Large Randomized Study in Adolescents and Adults with Asthma, Assessing the Safety and Efficacy of Salmeterol in Combination with Fluticasone Propionate Compared to Fluticasone Propionate Alone 2016 ·Journal of Allergy and Clinical Immunology ·David A. Stempel, Ibrahim Raphiou, Kenneth M. Kral, Anne Yeakey, (unknown), Amanda Emmett, Charlene M. Prazma, Steve Pascoe	2
15	Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma 2016 ·New England Journal of Medicine ·David A. Stempel, Stanley J. Szefler, Søren Pedersen, Robert S. Zeiger, Anne Yeakey, Laurie A. Lee, Andrew H. Liu, Herman Mitchell, Kenneth M. Kral, Ibrahim Raphiou, Barbara A. Prillaman, (unknown), Suyong Yun Kirby, Steven Pascoe	77
16	Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone 2016 ·New England Journal of Medicine ·David A. Stempel, Ibrahim Raphiou, Kenneth M. Kral, Anne Yeakey, Amanda Emmett, Charlene M. Prazma, (unknown), Steven Pascoe	104
17	LATE-BREAKING ABSTRACT: Safety of salmeterol/fluticasone propionate (FSC) compared to fluticasone propionate (FP) in 4-17 yr olds with asthma 2016 ·David A. Stempel, Stanley J. Szefler, Søren Pedersen, Robert S. Zeiger, Herman Mitchell, Andy Liu, Ibrahim Raphiou, Kenneth M. Kral, Anne Yeakey, (unknown), Barbara A. Prillaman, (unknown), Suyong Yun Kirby, Steven Pascoe	1
18	Patient Comprehension of Medication Guides for Asthma and Chronic Obstructive Pulmonary Disease Medications 2014 ·Therapeutic Innovation & Regulatory Science ·Rachael L. DiSantostefano, Melissa J. Beck, Anne Yeakey, Ibrahim Raphiou, David A. Stempel	2
19	An evaluation of asthma medication utilization for risk evaluation and mitigation strategies (REMS) in the United States: 2005–2011 2013 ·Journal of Asthma ·Rachael L. DiSantostefano, Anne Yeakey, Ibrahim Raphiou, David A. Stempel	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact